{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:53:05Z","timestamp":1781844785818,"version":"3.54.5"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Extracellular vesicles are shifting the paradigm in vaccine development by virtue of their diverse benefits as carriers of immunogens to targeted hosts. These nano-sized naturally occurring biomolecules offer safety, transmissibility across membranes, excellent presentation of antigens and robust immune responses when engineered as vaccine delivery vehicles. Given the remarkable potential of these nanoscale biological carriers, the scientific community has witnessed substantial escalation in research activity highlighting their applications in vaccines and drug delivery. However, the research is still in its early stage and the scientists are actively striving to optimize the engineering of these molecules for effective therapeutic applications. As a research group working on similar lines, we sought to explore the diverse engineering strategies with the aim of understanding the potential of extracellular vesicles as potent vaccine delivery vehicles. We conducted a systematic search to critically screen original research studies investigating engineering of extracellular vesicles for production of vaccines against viral infections. Our analysis of the studies revealed that extracellular vesicles provide diverse engineering opportunities to enable efficient viral antigen presentation, and to elicit robust immune responses both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . A wide spectrum of viruses has been targeted driving development of versatile as well as pathogen-specific vaccine strategies. Advancing research in this domain could deepen mechanistic insight into viral infections, while opening novel pathways for translational application, drug delivery and vaccine design. We conclude that substantial opportunities remain to fully harness the potential of extracellular vesicles in biomedical research, particularly in context of viral infections.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1820746","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:06Z","timestamp":1781843346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles as new-age vaccine carriers: a focused account on viral diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Roopali","family":"Rajput","sequence":"first","affiliation":[{"name":"Virology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi","place":["Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Khanna","sequence":"additional","affiliation":[{"name":"Virology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi","place":["Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Radhika","sequence":"additional","affiliation":[{"name":"Virology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi","place":["Delhi, India"]},{"name":"Department of Zoology, Ramjas College, University of Delhi","place":["Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Zoology, Ramjas College, University of Delhi","place":["Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B2","article-title":"Histology, extracellular vesicles","volume-title":"StatPearls","author":"Ibrahim","year":"2023"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.07.001","article-title":"Extracellular vesicles: novel promising delivery systems for therapy of brain diseases","volume":"262","author":"Rufino-Ramos","year":"2017","journal-title":"J Ctrl Release"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886701","article-title":"Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells","volume":"13","author":"Corsello","year":"2022","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440667","article-title":"Extracellular vesicles derived from antigen-presenting cells pulsed with foot and mouth virus vaccine-antigens act as carriers of viral proteins and stimulate B cell response","volume":"15","author":"Menay","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.17.11403-11411.2005","article-title":"The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity","volume":"79","author":"Alcon-LePoder","year":"2005","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism","volume":"26","author":"Puerta-Guardo","year":"2019","journal-title":"Cell Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v15020364","article-title":"Extracellular vesicles are conveyors of the NS1 toxin during dengue virus and Zika virus infection","volume":"15","author":"Safadi","year":"2023","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/v15040860","article-title":"A perspective on current flavivirus vaccine development: A brief review","volume":"15","author":"Dutta","year":"2023","journal-title":"Viruses"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/v13122363","article-title":"Deciphering the role of extracellular vesicles derived from ZIKV-infected hcMEC\/D3 cells on the blood-brain barrier system","volume":"13","author":"Fikatas","year":"2021","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071537","article-title":"Exosome-mediated delivery of inducible miR-423-5p enhances resistance of MRC-5 cells to rabies virus infection","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20240109","article-title":"Extracellular vesicle-based mRNA therapeutics and vaccines","volume":"5","author":"Li","year":"2025","journal-title":"Explor Beijing"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14030495","article-title":"Extracellular vesicles: A comprehensive review of their origins, functions, and therapeutic potential","volume":"14","author":"Schank","year":"2026","journal-title":"Biomedicines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.matt.2024.09.012","article-title":"Engineered extracellular vesicles as a next-generation vaccine platform","volume":"7","author":"Lu","year":"2024","journal-title":"Matter"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/inmd.70084","article-title":"Extracellular vesicle-based vaccines and immunotherapeutics for treatment of cancer","volume":"4","author":"Tan","year":"2026","journal-title":"Interdiscip Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.08.017","article-title":"Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity","volume":"374","author":"Luo","year":"2024","journal-title":"J Ctrl Release"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.16.7092-7106.2005","article-title":"WW domains provide a platform for the assembly of multiprotein networks","volume":"25","author":"Ingham","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade2708","article-title":"Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles","volume":"9","author":"Choi","year":"2023","journal-title":"Sci Adv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10899","DOI":"10.1038\/s41598-025-95503-y","article-title":"Membrane-targeted immunogenic compositions using exosome mimetic approach for vaccine development against SARS-CoV-2 and other pathogens","volume":"15","author":"Sahin","year":"2025","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/membranes11060428","article-title":"Surface modification of E. coli outer membrane vesicles with glycosylphosphatidylinositol-anchored proteins: Generating pro\/eukaryote chimera constructs","volume":"11","author":"ZAruba","year":"2021","journal-title":"Membranes Bsl"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215600119","article-title":"Enveloped viruses show increased propensity to cross-species transmission and zoonosis","volume":"119","author":"Valero-Rello","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.674277","article-title":"Clinical predictors of COVID-19 severity and mortality: A perspective","volume":"11","author":"Sharma","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12438","article-title":"Cell-engineered virus-mimetic nanovesicles for vaccination against enveloped viruses","volume":"13","author":"Han","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.4c00559","article-title":"Gag HIV-1 virus-like particles and extracellular vesicles functionalization with spike epitopes of SARS-CoV-2 using a copper-free click chemistry approach","volume":"36","author":"Garc\u00eda-Trujillo","year":"2025","journal-title":"Bioconjug Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12192","article-title":"A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants","volume":"11","author":"Jiang","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12412","article-title":"Bioengineered small extracellular vesicles deliver multiple SARS-CoV-2 antigenic fragments and drive a broad immunological response","volume":"13","author":"Jackson","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141826","article-title":"Oral delivery of mRNA vaccine by plant-derived extracellular vesicle carriers","volume":"12","author":"Pomatto","year":"2023","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104691","article-title":"Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells","volume":"386","author":"Young Chung","year":"2023","journal-title":"Cell Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/v14020329","article-title":"Strong SARS-CoV-2 N-specific CD8+ T immunity induced by engineered extracellular vesicles associates with protection from lethal infection in mice","volume":"14","author":"Ferrantelli","year":"2022","journal-title":"Viruses"},{"key":"B30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41541-023-00686-y","article-title":"Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles","volume":"8","author":"Manfredi","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108708","article-title":"SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model","volume":"27","author":"Cummings","year":"2023","journal-title":"iScience"},{"key":"B32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41551-022-00902-5","article-title":"Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine","volume":"6","author":"Wang","year":"2022","journal-title":"Nat BioMed Eng"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41467-024-45628-x","article-title":"Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290046","article-title":"Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants","volume":"18","author":"Cacciottolo","year":"2023","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100637","article-title":"Cutting edge: Circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer-BioNTech) vaccination prior to development of antibodies: A novel mechanism for immune activation by mRNA vaccines","volume":"207","author":"Bansal","year":"2021","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2012.0359","article-title":"Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice","volume":"22","author":"Rajput","year":"2012","journal-title":"Nucleic Acid Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00440","article-title":"Diagnostic potential of recombinant scFv antibodies generated against hemagglutinin protein of influenza A virus","volume":"6","author":"Rajput","year":"2015","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.025","article-title":"Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model","volume":"35","author":"Lee","year":"2017","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c08831","article-title":"Mature dendritic cell-derived extracellular vesicles are potent mucosal adjuvants for influenza hemagglutinin vaccines","volume":"19","author":"Dong","year":"2025","journal-title":"ACS Nano"},{"key":"B40","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ymthe.2017.01.010","article-title":"Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection","volume":"25","author":"Watkins","year":"2017","journal-title":"Mol Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00301.x","article-title":"Cross-presentation: underlying mechanisms and role in immune surveillance","volume":"207","author":"Rock","year":"2005","journal-title":"Immunol Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-005-1420-8","article-title":"Viral evasion of the MHC class I antigen processing machinery","volume":"451","author":"Loch","year":"2005","journal-title":"Pflugers Arch"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001768","article-title":"Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin","volume":"185","author":"Testa","year":"2010","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2174\/1568026620666200129094516","article-title":"Natural products as a paradigm for the treatment of Coxsackievirus - induced myocarditis","volume":"20","author":"Khanna","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666594","article-title":"An albumin-binding domain peptide confers enhanced immunoprotection against viral myocarditis by CVB3 VP1 vaccine","volume":"12","author":"Gao","year":"2021","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2022.12.015","article-title":"Exosome-based delivery of VP1 protein conferred enhanced resistance of mice to CVB3-induced viral myocarditis","volume":"579","author":"Zhang","year":"2023","journal-title":"Virology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2021.647836","article-title":"SARS-CoV-2 in pregnancy: Fitting into the existing viral repertoire","volume":"2","author":"Rajput","year":"2021","journal-title":"Front Glob Womens Health"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.026","article-title":"EVs containing host restriction factor IFITM3 inhibited ZIKV infection of fetuses in pregnant mice through trans-placenta delivery","volume":"29","author":"Zou","year":"2021","journal-title":"Mol Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(94)90269-0","article-title":"Avipox virus-vectored Japanese encephalitis virus vaccines: Use as vaccine candidates in combination with purified subunit immunogens","volume":"12","author":"Konishi","year":"1994","journal-title":"Vaccine"},{"key":"B50","doi-asserted-by":"publisher","first-page":"21358","DOI":"10.1038\/s41598-021-00765-x","article-title":"Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus","volume":"11","author":"Hong","year":"2021","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b03893","article-title":"Safe staphylococcal platform for the development of multivalent nanoscale vesicles against viral infections","volume":"18","author":"Yuan","year":"2018","journal-title":"Nano Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/v7031079","article-title":"HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response","volume":"7","author":"Di Bonito","year":"2015","journal-title":"Viruses"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.23","article-title":"Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway","volume":"14","author":"Wang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17487","DOI":"10.1038\/s41598-018-36141-5","article-title":"Targeted-pig trial on safety and immunogenicity of serum-derived extracellular vesicles enriched fractions obtained from Porcine Respiratory and Reproductive virus infections","volume":"8","author":"Montaner-Tarbes","year":"2018","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-014-0225-9","article-title":"Inhibition of porcine reproductive and respiratory syndrome virus infection by recombinant adenovirus- and\/or exosome-delivered the artificial microRNAs targeting sialoadhesin and CD163 receptors","volume":"11","author":"Zhu","year":"2014","journal-title":"Virol J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01156-25","article-title":"LPS\/TLR4-activated M1-polarized macrophage-derived exosomes enhance IBV vaccine efficacy in chickens","volume":"99","author":"Zhou","year":"2025","journal-title":"J Virol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70207","article-title":"Engineered low-endotoxin bacterial biomimetic vesicles for enhanced oral dual-antigen subunit vaccine delivery","volume":"14","author":"Shen","year":"2025","journal-title":"J Extracell Vesicles"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1820746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:08Z","timestamp":1781843348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1820746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2026.1820746"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1820746","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1820746"}}